Given that several such cytokines, such as TNF, IL‐1β, and IL‐6, are potent, nonredundant mediators of anti‐TB immunity, it is perhaps not surprising that their regulatory pathways represent attractive targets for dampening the host immune response to infection. The gene discussed is IL1B; the disease is infection.